UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000009797
Receipt No. R000011103
Scientific Title Phase II study of bendamustine, rituximab and cytarabine for patients with relapsed or refractory follicular lymphoma or mantle cell lymphoma
Date of disclosure of the study information 2013/01/17
Last modified on 2019/11/03 10:34:49

No. Disposal Last modified on Item of update
1 Insert 2013/01/17 16:56:38
2 Update 2013/05/04 14:46:15 Acronym
Acronym
3 Update 2014/02/02 00:40:28 TEL
Email
TEL
Email
TEL
Tel1
4 Update 2014/02/02 00:45:12 Organization
Division name
Email
Organization
5 Update 2015/01/17 20:51:07 URL releasing protocol
6 Update 2016/11/04 22:01:05 Name of primary sponsor
Organization
Institutions
7 Update 2019/11/03 10:23:56 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code
Email

Last name of contact person

Last name of contact person
Zip code
Email
Name of person sending information
Email1
Organization
Organization
Address
Address
Tel
Email
8 Update 2019/11/03 10:34:49 Date of IRB
Last follow-up date


Contact us.